Efficacy Study of Imatinib Mesylate to Treat Philadelphia-Positive Acute Lymphocytic Leukemia
Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to determine the efficacy and safety of imatinib mesylate in
patients diagnosed as having Philadelphia chromosome positive acute lymphocytic leukemia
(ALL).